Circulating Biomarkers in the Development of Type 1 Diabetes
Part of paid clinical trials in Duarte, California.
- Sponsor
- City of Hope Medical Center
- Study ID
- NCT05505669
- Status
- Recruiting
Conditions
- Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Interventions
- One-time blood (up to 100 ml) will be drawn and the amount of blood drawn is based on weight. Saliva and urine will be collected during the blood draw visit. — OTHEROne-time blood (up to 100 ml) will be drawn and the amount of blood drawn is based on weight. Saliva and urine will be collected during the blood draw visit.
Study Details
More than 100 million U.S. adults are now living with diabetes or prediabetes. Investigators still do not fully understand how diabetes develops and how the disease worsens. Insulin is a hormone that helps the body use sugar as a fuel and control blood-sugar levels. People with diabetes have problems making insulin. This is because their insulin-producing beta cells -in the pancreas-are damaged or destroyed. A biomarker is a biological molecule (such as DNA, RNA (the genetic material of cells) or protein) that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker can be measured and found in blood and/or other body fluids (such as saliva and urine). Understanding the biology of beta cells could help find diabetes-related biomarkers. The discoveries from this research could help with early diagnosis of diabetes and lead to the creation of therapies for treating diabetes.
Key Dates
- Start date
- Mar 29, 2022
- Status verified
- Jan 2026
- Primary completion
- Jun 9, 2026
- Completion
- Jun 9, 2026
Study Design
- Enrollment
- 165 participants (estimated)
Arms
- Arm: Adults with type 1 diabetesAdults with type 1 diabetes
- Arm: Adult healthy volunteersAdult healthy volunteers
- Arm: Children with type 1 diabetesChildren with type 1 diabetes
- Arm: Adults with type 2 diabetesAdults with type 2 diabetes
- Arm: Adults with high blood sugarAdults with high blood sugar
- Arm: Those at risk of developing type 1 diabetesThose at risk of developing type 1 diabetes
Primary Outcome Measure
Identification of circulating biomarkers that correlate with beta cell death in type 1 diabetes compared to healthy controls [ Time Frame: Baseline ]
Central Contacts
- Study Coordinator1-866-444-7538
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91010 |
Find similar trials in Duarte, CA
Related Studies
- Dementia and Diabetes Prevention ProgramRecruiting · University of California, Davis · Walnut Creek, California
- Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKDPHASE2 · Recruiting · University of California, Davis · Sacramento, California
- Addressing Diabetes by Elevating Access to NutritionRecruiting · Stanford University · Concord, California
- The Diabetes Prevention Program Outcomes Study AD/ADRD ProjectEnrolling By Invitation · Marinella Temprosa · Phoenix, Arizona